GeneDx Holdings WGS Free cash flow margin

Free cash flow margin at other companies

Natera, Inc.NTRA

4.2%-0.5pp

Fulgent Genetics, Inc.FLGT

-36.9%—

Tempus AI, Inc.TEM

-19.5%—

Personalis, Inc.PSNL

-131.2%-453pp

NeoGenomicsNEO

-4.9%—

Quest DiagnosticsDGX

11.7%0.0pp

FAQ

What is GeneDx Holdings's free cash flow margin?

GeneDx Holdings (WGS) reported free cash flow margin of 3.8% in Q3 2025.

How has GeneDx Holdings's free cash flow margin changed year-over-year?

GeneDx Holdings's free cash flow margin increased by 117.1% year-over-year, from -22.4% to 3.8%.

What is the long-term trend for GeneDx Holdings's free cash flow margin?

Over 3 years (2021 to 2024), GeneDx Holdings's free cash flow margin has grown at a -50.9% compound annual growth rate (CAGR), from -94.2% to -11.1%.

What does free cash flow margin mean?

Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.